These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

494 related articles for article (PubMed ID: 27718558)

  • 1. A Novel Methodology for Bioenergetic Analysis of Plasmodium falciparum Reveals a Glucose-Regulated Metabolic Shift and Enables Mode of Action Analyses of Mitochondrial Inhibitors.
    Sakata-Kato T; Wirth DF
    ACS Infect Dis; 2016 Dec; 2(12):903-916. PubMed ID: 27718558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rubella Viruses Shift Cellular Bioenergetics to a More Oxidative and Glycolytic Phenotype with a Strain-Specific Requirement for Glutamine.
    Bilz NC; Jahn K; Lorenz M; Lüdtke A; Hübschen JM; Geyer H; Mankertz A; Hübner D; Liebert UG; Claus C
    J Virol; 2018 Sep; 92(17):. PubMed ID: 29950419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondrial metabolism of sexual and asexual blood stages of the malaria parasite Plasmodium falciparum.
    MacRae JI; Dixon MW; Dearnley MK; Chua HH; Chambers JM; Kenny S; Bottova I; Tilley L; McConville MJ
    BMC Biol; 2013 Jun; 11():67. PubMed ID: 23763941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In silico multiple-targets identification for heme detoxification in the human malaria parasite Plasmodium falciparum.
    Phaiphinit S; Pattaradilokrat S; Lursinsap C; Plaimas K
    Infect Genet Evol; 2016 Jan; 37():237-44. PubMed ID: 26626103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional screening of selective mitochondrial inhibitors of Plasmodium.
    Gomez-Lorenzo MG; Rodríguez-Alejandre A; Moliner-Cubel S; Martínez-Hoyos M; Bahamontes-Rosa N; Gonzalez Del Rio R; Ródenas C; Fuente J; Lavandera JL; García-Bustos JF; Mendoza-Losana A
    Int J Parasitol Drugs Drug Resist; 2018 Aug; 8(2):295-303. PubMed ID: 29775797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic ablation of the mitoribosome in the malaria parasite
    Ling L; Mulaka M; Munro J; Dass S; Mather MW; Riscoe MK; Llinás M; Zhou J; Ke H
    J Biol Chem; 2020 May; 295(21):7235-7248. PubMed ID: 32273345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondrial oxygen consumption in asexual and sexual blood stages of the human malarial parasite, Plasmodium falciparum.
    Krungkrai J; Burat D; Kudan S; Krungkrai S; Prapunwattana P
    Southeast Asian J Trop Med Public Health; 1999 Dec; 30(4):636-42. PubMed ID: 10928353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combining Stage Specificity and Metabolomic Profiling to Advance Antimalarial Drug Discovery.
    Murithi JM; Owen ES; Istvan ES; Lee MCS; Ottilie S; Chibale K; Goldberg DE; Winzeler EA; Llinás M; Fidock DA; Vanaerschot M
    Cell Chem Biol; 2020 Feb; 27(2):158-171.e3. PubMed ID: 31813848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determining the Mode of Action of Antimalarial Drugs Using Time-Resolved LC-MS-Based Metabolite Profiling.
    Cobbold SA; McConville MJ
    Methods Mol Biol; 2019; 1859():225-239. PubMed ID: 30421232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microaerophilic respiratory metabolism of Plasmodium falciparum mitochondrion as a drug target.
    Torrentino-Madamet M; Desplans J; Travaillé C; James Y; Parzy D
    Curr Mol Med; 2010 Feb; 10(1):29-46. PubMed ID: 20205678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Metabolite Repair Enzyme Phosphoglycolate Phosphatase Regulates Central Carbon Metabolism and Fosmidomycin Sensitivity in Plasmodium falciparum.
    Dumont L; Richardson MB; van der Peet P; Marapana DS; Triglia T; Dixon MWA; Cowman AF; Williams SJ; Tilley L; McConville MJ; Cobbold SA
    mBio; 2019 Dec; 10(6):. PubMed ID: 31822583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of quinolone antimalarials targeting the Plasmodium falciparum mitochondrial respiratory chain for the treatment and prophylaxis of malaria.
    Biagini GA; Fisher N; Shone AE; Mubaraki MA; Srivastava A; Hill A; Antoine T; Warman AJ; Davies J; Pidathala C; Amewu RK; Leung SC; Sharma R; Gibbons P; Hong DW; Pacorel B; Lawrenson AS; Charoensutthivarakul S; Taylor L; Berger O; Mbekeani A; Stocks PA; Nixon GL; Chadwick J; Hemingway J; Delves MJ; Sinden RE; Zeeman AM; Kocken CH; Berry NG; O'Neill PM; Ward SA
    Proc Natl Acad Sci U S A; 2012 May; 109(21):8298-303. PubMed ID: 22566611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel Plasmodium falciparum metabolic network reconstruction identifies shifts associated with clinical antimalarial resistance.
    Carey MA; Papin JA; Guler JL
    BMC Genomics; 2017 Jul; 18(1):543. PubMed ID: 28724354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Farnesyltransferase Inhibitor R115777 on Mitochondria of Plasmodium falciparum.
    Ha YR; Hwang BG; Hong Y; Yang HW; Lee SJ
    Korean J Parasitol; 2015 Aug; 53(4):421-30. PubMed ID: 26323840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitochondrial type II NADH dehydrogenase of Plasmodium falciparum (PfNDH2) is dispensable in the asexual blood stages.
    Ke H; Ganesan SM; Dass S; Morrisey JM; Pou S; Nilsen A; Riscoe MK; Mather MW; Vaidya AB
    PLoS One; 2019; 14(4):e0214023. PubMed ID: 30964863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of
    Ramesh S; Cihalova D; Rajendran E; Van Dooren GG; Maier AG
    Bio Protoc; 2023 Nov; 13(21):e4863. PubMed ID: 37969754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Why is the Plasmodium falciparum hexose transporter a promising new drug target?
    Joët T; Morin C; Fischbarg J; Louw AI; Eckstein-Ludwig U; Woodrow C; Krishna S
    Expert Opin Ther Targets; 2003 Oct; 7(5):593-602. PubMed ID: 14498822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimalarial drugs and drug targets specific to fatty acid metabolic pathway of Plasmodium falciparum.
    Qidwai T; Khan F
    Chem Biol Drug Des; 2012 Aug; 80(2):155-72. PubMed ID: 22487082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting the Plasmodium vivax equilibrative nucleoside transporter 1 (PvENT1) for antimalarial drug development.
    Deniskin R; Frame IJ; Sosa Y; Akabas MH
    Int J Parasitol Drugs Drug Resist; 2016 Apr; 6(1):1-11. PubMed ID: 26862473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biological characterization of chemically diverse compounds targeting the Plasmodium falciparum coenzyme A synthesis pathway.
    Fletcher S; Lucantoni L; Sykes ML; Jones AJ; Holleran JP; Saliba KJ; Avery VM
    Parasit Vectors; 2016 Nov; 9(1):589. PubMed ID: 27855724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.